1. Home
  2. Stocks
  3. Astrazen Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Astrazeneca Pharma India Share Price AstraZeneca Pharma India

    Mid Cap
    ₹5,332.25
    +47.45 (0.9%)
    26 April, 2024 00:44 BSE: 506820 NSE: ASTRAZENISIN: INE203A01020

    Start SIP in AstraZeneca Pharma India

    Start SIP

    AstraZeneca Pharma India Performance

    Day Range

    • Low 5,288
    • High 5,374
    ₹ 5,332

    52 Week Range

    • Low 3,115
    • High 7,221
    ₹ 5,332
    • Open Price5,322
    • Previous Close5,285
    • Volume3817

    AstraZeneca Pharma India Share Price

    • Over 1 Month +3.93%
    • Over 3 Month -16.84%
    • Over 6 Month +16.42%
    • Over 1 Year +69.6%

    AstraZeneca Pharma India Key Statistics

    P/E Ratio 95.7
    PEG Ratio 3.6
    Market Cap Cr 13,331
    Price to Book Ratio 22.6
    EPS 50.5
    Dividend 0.3
    Relative Strength Index 53.29
    Money Flow Index 77.1
    MACD Signal -31.75
    Average True Range 151.2
    AstraZeneca Pharma India Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 306311295285
    Operating Expenses Qtr Cr 291258228225
    Operating Profit Qtr Cr 15536760
    Depreciation Qtr Cr 4444
    Interest Qtr Cr 1100
    Tax Qtr Cr 521186
    Net Profit Qtr Cr 16525417
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,029
    Operating Expenses Annual Cr 838
    Operating Profit Annual in Cr 165
    Depreciation Cr 16
    Interest Annual Cr 1
    Tax Annual Cr 35
    Net Profit Annual Cr 99
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 58
    Cash from Investing Activity Annual Cr 18
    Cash from Financing Annual Activity Cr -24
    Net Cash Flow Annual Cr 52
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 589
    Fixed Assets Annual Cr 70
    Total Non Current Assets Annual Cr 149
    Total Current Assets Annual Cr 835
    Total Assets Annual Cr 985
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 235
    ROE Annual % 17
    ROCE Annual % 29
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 19
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in AstraZeneca Pharma India

    AstraZeneca Pharma India Technicals

    EMA & SMA

    Current Price
    ₹5,332.25
    +47.45 (0.9%)
    pointer
    • Bullish Moving Average
    • ___
    • 14
    • Bearish Moving Average
    • ___
    • 2
    • 20 Day
    • ₹5,258.79
    • 50 Day
    • ₹5,342.27
    • 100 Day
    • ₹5,292.12
    • 200 Day
    • ₹4,937.40
    • 20 Day
    • ₹5,242.65
    • 50 Day
    • ₹5,304.58
    • 100 Day
    • ₹5,491.67
    • 200 Day
    • ₹4,907.37

    AstraZeneca Pharma India Resistance and Support

    PIVOT
    ₹5,331.45
    Resistance
    First Resistance 5,374.80
    Second Resistance 5,417.35
    Third Resistance 5,460.70
    RSI 53.29
    MFI 77.10
    MACD Single Line -31.75
    MACD -11.60
    Support
    First Resistance 5,288.90
    Second Resistance 5,245.55
    Third Resistance 5,203.00

    AstraZeneca Pharma India Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 4,071 166,015 40.78
    Week 7,884 504,825 64.03
    1 Month 22,888 1,420,171 62.05
    6 Month 29,209 976,157 33.42

    AstraZeneca Pharma India Result Highlights

    AstraZeneca Pharma India Synopsis

    NSE-Medical-Diversified

    Astrazeneca Pharma I is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1002.97 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2023. AstraZeneca Pharma India Ltd. is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563.
    Market Cap 13,240
    Sales 1,197
    Shares in Float 0.63
    No of funds 120
    Yield 0.3
    Book Value 22.44
    U/D Vol ratio 0.5
    LTDebt / Equity
    Alpha 0.15
    Beta 0.68

    AstraZeneca Pharma India

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 75%75%75%75%
    Mutual Funds 3.75%2.75%2.42%1.76%
    Insurance Companies
    Foreign Portfolio Investors 2.73%2.66%2.69%2.68%
    Financial Institutions/ Banks
    Individual Investors 16.34%17.09%17.44%18.12%
    Others 2.18%2.5%2.45%2.44%

    AstraZeneca Pharma India Management

    Name Designation
    Mr. Narayan K Seshadri Chairman & Ind.Director
    Mr. Sanjeev Kumar Panchal Executive Director
    Mr. Rajesh Marwaha Executive Director
    Mr. Ankush Nandra Non Executive Director
    Ms. Shilpa Shidhar Divekar Independent Director
    Ms. Weiying Sarah Wang Non Executive Director
    Ms. Revathy Ashok Independent Director

    AstraZeneca Pharma India Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    AstraZeneca Pharma India Corporate Action

    Date Purpose Remarks
    2024-02-08 Quarterly Results
    2023-11-09 Quarterly Results
    2023-08-14 Quarterly Results
    2023-05-30 Audited Results & Dividend
    2023-02-10 Quarterly Results
    Date Purpose Remarks
    2023-07-14 FINAL Rs.16.00 per share(800%)Dividend
    2022-07-08 FINAL Rs.8.00 per share(400%)Final Dividend
    2021-08-20 INTERIM Rs.2.00 per share(100%)Interim Dividend

    AstraZeneca Pharma India MF Shareholding

    Name Amount(cr)
    Nippon India Small Cap Fund - Growth 45,749
    Nippon India Pharma Fund - Growth 7,125
    ICICI Prudential Innovation Fund Regular Growth 4,453
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3,772
    ICICI Prudential MNC Fund Regular Growth 1,589

    AstraZeneca Pharma India FAQs

    What is Share Price of AstraZeneca Pharma India ?

    AstraZeneca Pharma India share price is ₹5,332 As on 26 April, 2024 | 00:30

    What is the Market Cap of AstraZeneca Pharma India ?

    The Market Cap of AstraZeneca Pharma India is ₹13330.6 Cr As on 26 April, 2024 | 00:30

    What is the P/E ratio of AstraZeneca Pharma India ?

    The P/E ratio of AstraZeneca Pharma India is 95.7 As on 26 April, 2024 | 00:30

    What is the PB ratio of AstraZeneca Pharma India ?

    The PB ratio of AstraZeneca Pharma India is 22.6 As on 26 April, 2024 | 00:30

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.